Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 445 | 2021 |
Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study M Schmidt, D Hajage, G Lebreton, A Monsel, G Voiriot, D Levy, E Baron, ... The Lancet Respiratory Medicine 8 (11), 1121-1131, 2020 | 394 | 2020 |
New insights into the pathogenesis of Behcet's disease MP de Chambrun, B Wechsler, G Geri, P Cacoub, D Saadoun Autoimmunity reviews 11 (10), 687-698, 2012 | 366 | 2012 |
X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021 | 339 | 2021 |
Extracorporeal membrane oxygenation network organisation and clinical outcomes during the COVID-19 pandemic in Greater Paris, France: a multicentre cohort study G Lebreton, M Schmidt, M Ponnaiah, T Folliguet, M Para, J Guihaire, ... The Lancet Respiratory Medicine 9 (8), 851-862, 2021 | 172 | 2021 |
Timing of initiation of renal-replacement therapy in acute kidney injury STARRT-AKI Investigators New England Journal of Medicine 383 (3), 240-251, 2020 | 157 | 2020 |
Ventilator-associated pneumonia in patients with SARS-CoV-2-associated acute respiratory distress syndrome requiring ECMO: a retrospective cohort study CE Luyt, T Sahnoun, M Gautier, P Vidal, S Burrel, ... Annals of Intensive Care 10 (1), 158, 2020 | 133 | 2020 |
Systemic inflammatory response syndrome is a major contributor to COVID-19–associated coagulopathy: insights from a prospective, single-center cohort study P Masi, G Hékimian, M Lejeune, J Chommeloux, C Desnos, ... Circulation 142 (6), 611-614, 2020 | 133 | 2020 |
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ... Proceedings of the National Academy of Sciences 119 (21), 2022 | 130 | 2022 |
Withdrawal of low-dose prednisone in SLE patients with a clinically quiescent disease for more than 1 year: a randomised clinical trial A Mathian, M Pha, J Haroche, F Cohen-Aubart, M Hié, MP de Chambrun, ... Annals of the Rheumatic Diseases 79 (3), 339-346, 2020 | 128 | 2020 |
Coronavirus disease 2019 acute myocarditis and multisystem inflammatory syndrome in adult intensive and cardiac care units G Hékimian, M Kerneis, M Zeitouni, F Cohen-Aubart, J Chommeloux, ... Chest 159 (2), 657-662, 2021 | 108 | 2021 |
Venoarterial extracorporeal membrane oxygenation for refractory cardiogenic shock post-cardiac arrest MP De Chambrun, N Bréchot, G Lebreton, M Schmidt, G Hekimian, ... Intensive care medicine 42, 1999-2007, 2016 | 91 | 2016 |
High frequency of antiphospholipid antibodies in critically ill COVID‐19 patients: a link with hypercoagulability? MP de Chambrun, C Frere, M Miyara, Z Amoura, I Martin‐Toutain, ... Journal of internal medicine 289 (3), 422, 2021 | 86 | 2021 |
Intravenous immunoglobulins improve survival in monoclonal gammopathy-associated systemic capillary-leak syndrome MP de Chambrun, M Gousseff, W Mauhin, JC Lega, M Lambert, S Rivière, ... The American journal of medicine 130 (10), 1219. e19-1219. e27, 2017 | 76 | 2017 |
Ultrasensitive serum interferon-α quantification during SLE remission identifies patients at risk for relapse A Mathian, S Mouries-Martin, K Dorgham, H Devilliers, H Yssel, ... Annals of the rheumatic diseases 78 (12), 1669-1676, 2019 | 74 | 2019 |
The clinical picture of severe systemic capillary-leak syndrome episodes requiring ICU admission MP de Chambrun, CE Luyt, F Beloncle, M Gousseff, W Mauhin, L Argaud, ... Critical care medicine 45 (7), 1216-1223, 2017 | 74 | 2017 |
Behcet’s disease in Budd-Chiari syndrome AC Desbois, PE Rautou, L Biard, N Belmatoug, B Wechsler, ... Orphanet Journal of Rare Diseases 9, 1-9, 2014 | 73 | 2014 |
Clinical features and outcome of patients with acute respiratory failure revealing anti-synthetase or anti-MDA-5 dermato-pulmonary syndrome: a French multicenter retrospective … C Vuillard, M Pineton de Chambrun, N De Prost, C Guérin, M Schmidt, ... Annals of Intensive Care 8, 1-12, 2018 | 62 | 2018 |
Abatacept/ruxolitinib and screening for concomitant respiratory muscle failure to mitigate fatality of immune-checkpoint inhibitor myocarditis JE Salem, M Bretagne, B Abbar, S Leonard-Louis, S Ederhy, A Redheuil, ... Cancer Discovery 13 (5), 1100-1115, 2023 | 56 | 2023 |
Venoarterial extracorporeal membrane oxygenation in cardiogenic shock: indications, mode of operation, and current evidence MP de Chambrun, N Brechot, A Combes Current Opinion in Critical Care 25 (4), 397-402, 2019 | 56 | 2019 |